Restricted accessResearch articleFirst published online 2017-07
Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy
HIV-1 reservoirs are most often studied in peripheral blood (PB), but not all lymphocytes recirculate, particularly T follicular helper (Tfh) CD4+ T cells, as well as germinal center (GC) B cells, in lymph nodes (LNs). Ultrasound-guided fine needle biopsies (FNBs) from inguinal LNs and PB samples were obtained from 10 healthy controls (HCs) and 21 HIV-1-infected subjects [11 antiretroviral therapy (ART) naive and 10 on ART]. Tfh cells and GC B cells were enumerated by flow cytometry. HIV-1 DNA and cell-associated (CA) RNA levels in LNs and PB were quantified by real-time polymerase chain reaction. FNBs were obtained without adverse events. Tfh cells and GC B cells were highly elevated in ART-naive subjects, with a median GC B cell count >300-fold higher than HCs, but also remained higher in 4 out of the 10 subjects on ART. GC B cell counts and Tfh cell counts were highly correlated with each other, and also with activated T cells in LNs but not in blood. Levels of HIV-1 DNA and CA RNA viral burden in highly purified CD4+ T cells from FNBs were significantly elevated compared with those in CD4+ T cells from PB in the ART-naive group, but only trended toward an increase in the ART patients. FNBs enabled minimally invasive access to, and parallel measurement of residual activated T and B cells and viral burden within LNs in HIV-1-infected patients. These FNBs revealed significant GC activity that was not apparent from corresponding PB samples.
Get full access to this article
View all access options for this article.
References
1.
ReidAJ, MillerRF, KocjanGI: Diagnostic utility of fine needle aspiration (FNA) cytology in HIV-infected patients with lymphadenopathy. Cytopathology, 1998; 9:230–239.
2.
MeylanPR, BurgisserP, Weyrich-SuterC, SpertiniF: Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol, 1996; 13:39–47.
3.
PantaleoG, FauciAS: Immunopathogenesis of HIV infection. Annu Rev Microbiol, 1996; 50:825–854.
4.
HongJJ, AmanchaPK, RogersK, AnsariAA, VillingerF: Spatial alterations between CD4+ T follicular helper, B, and CD8+ T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol, 2012; 188:3247–3256.
5.
LindqvistM, van LunzenJ, SoghoianDZ, et al.: Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest, 2012; 122:3271–3280.
6.
PerreauM, SavoyeAL, De CrignisE, et al.: Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med, 2013; 210:143–156.
7.
ColineauL, RouersA, YamamotoT, et al.: HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation. PLoS One, 2015; 10:e0140978.
8.
XuY, WeatherallC, BaileyM, et al.: Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol, 2013; 87:3760–3773.
9.
PhetsouphanhC, XuY, ZaundersJ: CD4 T cells mediate both positive and negative regulation of the immune response to HIV infection: Complex role of T follicular helper cells and regulatory T cells in pathogenesis. Front Immunol, 2014; 5:681.
10.
ConnickE, MattilaT, FolkvordJM, et al.: CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol, 2007; 178:6975–6983.
11.
FukazawaY, LumR, OkoyeAA, et al.: B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat Med, 2015; 21:132–139.
12.
HaaseAT: Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol, 1999; 17:625–656.
13.
ChunTW, EngelD, BerreyMM, SheaT, CoreyL, FauciAS: Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A, 1998; 95:8869–8873.
14.
ZaundersJJ, CunninghamPH, KelleherAD, et al.: Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: Partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis, 1999; 180:320–329.
15.
HoenB, DumonB, HarzicM, et al.: Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: Results of the ANRS 053 trial. J Infect Dis, 1999; 180:1342–1346.
16.
StrainMC, LittleSJ, DaarES, et al.: Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis, 2005; 191:1410–1418.
17.
KoelschKK, BoeseckeC, McBrideK, et al.: Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir. AIDS, 2011; 25:2069–2078.
18.
HocquelouxL, Avettand-FenoelV, JacquotS, et al.: Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J Antimicrob Chemother, 2013; 68:1169–1178.
19.
AnanworanichJ, DubeK, ChomontN: How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?. Curr Opin HIV AIDS, 2015; 10:18–28.
20.
LaananiM, GhosnJ, EssatA, et al.: Impact of the Timing of initiation of antiretroviral therapy during primary HIV-1 infection on the decay of cell-associated HIV-DNA. Clin Infect Dis, 2015; 60:1715–1721.
21.
MurrayJM, ZaundersJJ, McBrideKL, et al.: HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during ART. J Virol, 2014; 88:3516–3526.
22.
DouekDC: Immune activation, HIV persistence, and the cure. Top Antivir Med, 2013; 21:128–132.
23.
FletcherCV, StaskusK, WietgrefeSW, et al.: Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A, 2014; 111:2307–2312.
24.
ErikssonS, GrafEH, DahlV, et al.: Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog, 2013; 9:e1003174.
25.
XuY, FernandezC, AlcantaraS, et al.: Serial study of lymph node cell subsets using fine needle aspiration in pigtail macaques. J Immunol Methods, 2013; 394:73–83.
26.
RoskellDE, BuleyID: Fine needle aspiration cytology in cancer diagnosis. BMJ, 2004; 329:244–245.
27.
BurgisserP, SpertiniF, Weyrich-SuterC, PaganiJL, MeylanPR: Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration. J Infect Dis, 1997; 175:1202–1205.
28.
BartPA, MeuwlyJY, CorpatauxJM, et al.: Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study. AIDS, 1999; 13:1503–1509.
29.
FleuryS, RizzardiGP, ChapuisA, et al.: Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A, 2000; 97:5393–5398.
30.
ZaundersJJ, DyerWB, WangB, et al.: Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood, 2004; 103:2238–2247.
31.
PalmerS, WiegandAP, MaldarelliF, et al.: New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol, 2003; 41:4531–4536.
32.
LoweSM, KocjanGI, EdwardsSG, MillerRF: Diagnostic yield of fine-needle aspiration cytology in HIV-infected patients with lymphadenopathy in the era of highly active antiretroviral therapy. Int J STD AIDS, 2008; 19:553–556.
33.
PetrovasC, YamamotoT, GernerMY, et al.: CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest, 2012; 122:3281–3294.
34.
SchackerTW, NguyenPL, MartinezE, et al.: Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. J Infect Dis, 2002; 186:1092–1097.
35.
AnderssonJ, BoassoA, NilssonJ, et al.: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol, 2005; 174:3143–3147.
36.
NilssonJ, BoassoA, VelillaP, et al.: HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood, 2006; 108:3808–3817.
37.
Schulze Zur WieschJ, ThomssenA, HartjenP, et al.: Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol, 2011; 85:1287–1297.
38.
SeddikiN, CookL, HsuDC, et al.: Human antigen-specific CD4(+) CD25(+) CD134(+) CD39(+) T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses. Eur J Immunol, 2014; 44:1644–1661.
39.
MoirS, FauciAS: B cells in HIV infection and disease. Nat Rev Immunol, 2009; 9:235–245.
40.
CubasR, MuddJ, SavoyeA, et al.: Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med, 2013; 19:494–499.
41.
ImalY, YamakawaM: Morphology, function and pathology of follicular dendritic cells. Pathol Int, 1996; 46:807–833.
DeeksSG, LewinSR, HavlirDV: The end of AIDS: HIV infection as a chronic disease. Lancet, 2013; 382:1525–1533.
44.
MoritaR, SchmittN, BentebibelSE, et al.: Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity, 2011; 34:108–121.
45.
BoswellKL, ParisR, BoritzE, et al.: Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog, 2014; 10:e1003853.
46.
McMichaelAJ, BorrowP, TomarasGD, GoonetillekeN, HaynesBF: The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol, 2010; 10:11–23.
47.
McHeyzer-WilliamsM, OkitsuS, WangN, McHeyzer-WilliamsL: Molecular programming of B cell memory. Nat Rev Immunol, 2012; 12:24–34.
48.
ArsenioJ, KakaradovB, MetzPJ, KimSH, YeoGW, ChangJT: Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat Immunol, 2014; 15:365–372.
49.
PhetsouphanhC, ZaundersJJ, KelleherAD: Detecting antigen-specific T cell responses: From bulk populations to single cells. Int J Mol Sci, 2015; 16:18878–18893.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
